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  Newcastle disease (ND) caused by virulent Newcastle disease 
virus (NDV) is a highly contagious viral disease of poultry. 
Virulent NDVs characteristically have a multibasic amino 
acid sequence (virulence motif) such as 
112RRQKRF
117 at the 
cleavage site of the precusor fusion (F0) protein. The antigenic 
and  immunogenic  characteristics  of  the  virulence  motif 
112RRQKRF
117 in the F0 protein of virulent NDVs were 
investigated.  Epitope  mapping  analysis  revealed  that  a 
RRQKRF-specific monoclonal antibody 4G2 recognized the 
KRF section of the motif. A synthetic peptide bearing the 
RRQKRF motif reacted strongly with sera from virulent 
NDV (with RRQKRF motif)-infected chickens. These sera 
also showed reactivity to peptides bearing other virulence 
motifs (
112KRQKRF
117, 
112RRQRRF
117 and 
112RRRKRF
117) 
but not an avirulence motif (
112GRQGRL
117) by ELISA. The 
synthetic bearing RRQKRF motif reacted with 60% to 91% 
of sera taken from surviving chickens on ND outbreak farms 
but not with sera from vaccinated birds, even though most of 
the  sera  had  antibody  to  NDV  due  to  vaccination.  This 
indicates  that  the  virulence  motif  has  the  potential  to 
differentiate virulent NDV infected birds from vaccinated 
birds.
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Introduction
Newcastle disease virus (NDV) is a member of the avian 
paramyxovirus (APMV) group belonging to the Avulavirus 
genus in the family Paramyxoviridae  [26]. There are 
currently nine known antigenic serotypes of AMPV, 
designated APMV-1 through -9. NDV is the sole member 
of APMV-1 and is an enveloped virus with a negative-sense, 
single stranded RNA genome which codes for six structural 
and two non-structural proteins [7,14]. The structural 
proteins include nucleocapsid (N), phospho- (P), and matrix 
(M) proteins, fusion (F) and hemagglutinin-neuraminidase 
(HN) glycoproteins, and a large polymerase (L). Of these, 
the HN and F proteins are membrane anchored viral 
glycoproteins that enable cell binding and infection. The HN 
glycoprotein recognizes sialic acid containing receptors on 
cell surfaces and acts as a neuraminidase, removing sialic 
acid from progeny virus particles. The F protein is presumed 
to mediate membrane fusion either at the cell surface [8] or 
through receptor-mediated endocytosis [5].
Newcastle disease (ND) caused by virulent ND virus is 
one of the most devastating infectious diseases of poultry 
and induces up to 100% mortality as well as a decrease in 
egg production and poor egg quality [4]. NDV strains are 
classified into lentogenic, mesogenic, and velogenic 
categories, a nomenclature which reflects increasing levels 
of virulence for chickens based on biological parameters 
such as mean intracerebral pathogenicity index. 
The molecular determinant for NDV virulence is known 
to be related to the cleavability of precusor F (F0) to active 
F1 and F2 polypeptides by cellular proteases [13,18,23]. 
Virulent NDVs have a multibasic amino acid sequence (i.e. 
112RRQKRF
117) at the F0 cleavage site (virulence motif), 
whereas low virulent NDVs have a monobasic amino acid 
sequence (i.e. 
112GRQGRL
117) in the same region (avirulence 
motif) [2,6,21]. Most of the recent virulent NDV strains 
bear the virulence motif 
112RRQKRF
117 at the cleavage site 
of their F0 protein [1,15,17,21]. 
Polyclonal anti-peptide sera to peptides whose sequences 
mimic the F2-polypeptide C-termini (i.e. 
112RRQ
114) have 
been used to detect specifically virulent NDV isolates [12, 
16,25]. Despite the usefulness of its diagnostic applications, 
the antigenic and immunogenic properties of the motif still 
remain unclear. In this study, we map a B-cell epitope of the 
virulence motif 
112RRQKRF
117 and investigate whether the 
antibody response to the B-cell epitope on the virulence 
motif is induced in virulent NDV-infected chickens.206    Kang-Seuk Choi et al.
Fig. 1. Fine mapping of the epitope within the virulence motif 
112RRQKRF
117 which is recognized by the anti-RRQKRF 
monoclonal antibody 4G2, using indirect ELISA. The BSA- 
conjugated peptides are designated in terms of the alanine 
substitution that was made, e.g. peptide R112A bears an arginine
(R) to alanine (A) substitution at residue 112 of the fusion protein.
BSA: bovine serum albumin.
Materials and Methods
Synthetic peptides
The synthetic peptide RRQKRF (CAARRQKFRI) 
containing the virulence motif RRQKRF was synthesized 
by a commercial company (Peptron, Korea) using Fmoc (9- 
fluorenylmethoxycarboxyl) solid-phase synthesis chemistry 
on Rink amide resin (Novabiochem, USA). The peptide was 
subjected to C-terminal amidation to stabilize its structure. 
Six peptides were prepared by an alanine substitution of the 
112RRQKRF
117 motif with at each position (e.g. R112A 
represents an arginine to alanine substitution at residue 112; 
Fig. 1). Four synthetic peptides containing other virulence 
motif (KRQKRF, RRQRRF and RRRKRF) or avirulence 
motif (GRQGRL) sequences were also synthesized in the 
same manner. Each peptide was then conjugated to bovine 
serum albumin (BSA) for enzyme-linked immunosorbent 
assay (ELISA).
Anti-RRQKRF antibodies
Anti-RRQKRF monoclonal antibody (mAb) 4G2 was 
used in this study. The hybridoma cell line producing mAb 
4G2 (IgG1, kappa) was generated from mice immunized 
with the keyhole limpet haemocyanin (KLH)-conjugated 
synthetic peptide CGGRRQKRFI in our laboratory. Ascitic 
fluids were produced following inoculation of 10
7 hybridoma 
cells into the peritoneal cavities of pristine-primed Balb/c 
mice as described elsewhere.
Anti-RRQKRF sera were prepared from chickens (n = 2) 
by two subcutaneous inoculations with the KLH- 
CAARRQKFRI peptide conjugate (100 μg per bird in 
complete Freund’s adjuvant for the primary inoculation 
and in incomplete Freund’s adjuvant for the booster) at 
three week intervals. Sera were taken from immunized 
birds 3 weeks after the last inoculation. Sera were diluted in 
pre-immune chicken sera and then titrated by ELISA. 
Diluted serum having 25% of the highest optical density 
(OD) value in ELISA was used as positive serum control. 
Pre-immune chicken sera served as negative serum control.
Virus
NDV strain Kr-005/00 was used in this study. This strain 
is a highly virulent NDV strain having the virulence motif 
112RRQKRF
117 at the cleavage site of the F0 protein [15]. 
NDV was propagated by using SPF chicken eggs, and 
stored at 򰠏70
oC until use.
Animal experiment
Six week-old specific pathogen-free (SPF) chickens from 
White Leghorn parents (Lohmann, Germany) were used in 
this study. The SPF birds were maintained in air-filtered 
bio-security isolation units (ThreeShine, Korea) with feed 
and water ad libitum for the duration of the study. All animals 
were kept at animal facilities and we followed the ethical 
guidelines of the Animal Welfare Committee recommended 
by the National Veterinary Research and Quarantine Service 
during the experiment. A total of 24 six-week old SPF 
chickens in this experiment were divided into two groups for 
the experiment. The infection group was challenged with 
Kr-005/00 (10
4.5 EID50/100 μL) (n = 12, 100 μL per bird) via 
the eye drop and intranasal (ED/ IN) routes. Control birds 
(n = 12) were sham challenged with the same volume (100 
μL) of PBS via the ED/IN route. All birds were monitored 
daily for overt clinical signs (depression, respiratory signs, 
diarrhea etc.) and mortality. Serum and cloacal samples were 
taken twice on days 0 and 7 post-inoculation.
Virus re-isolation
The swab samples collected for virus isolation were placed 
in 3 mL transport medium (Micro Test M4RT; Remel, 
USA) and stored at 򰠏70
oC until use for virus isolation. For 
this, the samples were first clarified by centrifugation at 
3,000 g for 10 min and then 100 μL of the supernatant was 
inoculated into allantoic cavity of 9 to 11 day-old SPF 
embryonated chicken eggs. 
Hemagglutination inhibition (HI) test
Serum titers to NDV were determined by HI tests in V- 
bottom microtiter plates as described elsewhere [3]. Thus, 
two-fold dilutions of test sera in PBS, pH7.4, were mixed 
with the same volume containing 4 HA units of NDV HA 
antigen (Daesung Microbiological Laboratory, Korea). The 
mixture (50 μL per well) was then incubated at room 
temperature for 30 min. An equal volume of 0.5% chicken 
RBC in PBS was added. The HI endpoint was determined Antigenic and immunogenic NDV virulence motif    207
Table 1. ELISA results of sera from chickens on Newcastle disease (ND) outbreak farms and normal farms as compared with 
hemagglutination inhibition (HI) test results
Farm Breed* Age (day old) ND vaccination HI result
† ELISA result
‡
With ND outbreak
A 
B
C
D
E
Br
Ly 
Kn
Kn
Br
35
39
50
28
42
Yes
Yes
Yes
Yes
Yes
90% (18/20)
82% (18/22)
NT
NT
NT
90% (18/20)
a
91% (20/22)
a
65% (13/20)
a
60% (9/15)
a
88% (14/16)
a
Without ND outbreak
F 
G
Br 
Br
35
32
Yes
Yes
85%(17/20)
55%(11/20)
5% (1/20)
b
0% (0/20)
b
*Br, broiler chicken; Ly, layer chicken; Kn, Korean native chicken. 
†The data in parentheses represent the number of positive chicken 
sera/number of tested chicken sera. Sera having HI titers of 2 or greater were considered positive. NT, not tested. 
‡The data in parentheses 
represent the number of positive chicken sera/number of tested chicken sera. Sera having PP values of 20% or greater were considered positive.
a,bValues with different superscripts within a column are significantly different (p＜0.05).
as the last dilution that showed complete inhibition of HA 
activity. All tests were repeated twice. The HI titers are 
expressed as reciprocal log2 in this study. 
Peptide based ELISA (pELISA)
The BSA (diluted in 0.01M PBS, pH7.4) was coated on an 
ELISA plate (Maxisorp; Nunc, France) at 37
oC for 2 h. Each 
serum or mAb sample (50 μL per well) was incubated in two 
test wells in the ELISA for 1 h. Here, sera and mAb 4G2 were 
used at dilutions of 1 : 100 and 1 : 2,500, respectively, in 
blocking buffer (0.2% Tween 20 and 2% BSA in 0.01 M PBS). 
The antigen-antibody reaction was visualized by use of 
horseradish peroxidase-conjugated 5D2 antibody (BioNote, 
Korea) or horseradish peroxidase- conjugated anti-mouse 
IgG (H + L) antibody (Kirkegaard & Perry Laboratories, 
USA) (100 μL/well, diluted 1：1,500 in blocking buffer) 
and then TMB (3, 3´, 5, 5´-tetramethylbenzidine) solution 
(Sigma, USA). ELISA OD was measured at a wavelength 
of 450 nm. The net OD of each serum was calculated by 
subtracting the OD value of the control negative well from 
the mean OD value of the peptide-coated wells. The OD of 
each well was converted to a percent positive (PP) value of 
mAb bound to serum antibodies using the following 
formula: PP = (net OD of test serum/net OD of positive 
control serum) × 100. Sera having a PP value of 20% or more 
were considered positive.
Field samples
The sera (n = 93) taken from surviving chickens on five 
farms with ND outbreak were used in this study (Table 1). 
At the time of sampling, virulent NDV (bearing the RRQKRF 
motif) was isolated from tissue samples (trachea, cecal 
tonsil and kidney) from the dead birds (data not shown). 
For comparison, normal sera (n = 40) taken from apparently 
healthy chickens on two farms with no ND outbreak were 
also used. All chickens had received at least two vaccinations 
with live NDV vaccines (1 and 10 to 14 days) before 
bleeding. All sera were tested by pELISA using synthetic 
peptide bearing RRQKRF motif. The results obtained by 
pELISA were compared with the HI test.
Statistical analysis
The pELISA and HI data from serum samples are presented 
as mean ± SD. Differences in the antibody titers between 
groups were analyzed by using the Mann-Whitney U test. 
Significance was accepted at p＜0.05.
Results
Epitope  mapping  of  virulence  motif  of  NDV  F 
protein using monoclonal antibody 4G2
Virulence motif specific-monoclonal antibody 4G2 was used 
for mapping B-cell epitope on virulence motif 
112RRQKRF
117. 
The peptide antigens (RRQKRF, R112A, R113A, Q114A, 
K115A, R116A and F117A) were tested at a concentration 
of 4 μg/mL by indirect ELISA using mAb 4G2. As expected, 
the 4G2 antibody reacted strongly with peptide RRQKRF. 
It also reacted strongly (ELISA absorbance of ＞1.5) with 
peptides R112A, R113A and Q114A, and weakly (ELISA 
absorbance of 0.68) with peptide K115A. It did not react 
detectably (ELISA absorbance of ＜0.2) with peptides 
R116A, F117A and BSA alone (Fig. 1). This indicates that 
the 4G2 antibody recognizes the amino acid sequence of the 
115KRF117 sequence in the virulence motif of the F protein.
Reactivity  of  RRQKRF  motif  to  sera  from  NDV 
infected chickens
The immune response to the virulence motif was then 208    Kang-Seuk Choi et al.
Fig. 2. Reactivity of synthetic peptide RRQKRF to sera obtained
from four chickens 0 and 7 days post-infection (dpi) with a 
virulent Newcastle disease virus (NDV) strain. Four (5-1, 5-2, 
5-5 and 5-12) of 12 infected birds with virulent NDV survived 7 
dpi. Surviving birds were tested 0 and 7 dpi. ELISA results of 
each serum tested was compared to HI titer (log2). Serum having 
PP value ≥ 20% in the pELISA was considered positive.
Fig. 3. Reactivity of anti-NDV chicken sera to synthetic peptides
mimicking four virulence motifs (KRQKRF, RRQRRF and 
RRRKRF) and one avirulence motif (GRQGRL), as determined
by indirect ELISA. These sera were obtained from four chickens
0 and 7 dpi after they were challenged with a virulent NDV strain.
examined by pELISA using the BSA-conjugated peptide 
RRQKRF and sera obtained from virulent NDV infected 
SPF chickens. SPF chickens were challenged with virulent 
NDV Kr005 with RRQKRF motif. Prior to the NDV 
challenge, none of the birds exhibited clinical signs of overt 
ND and the virus could not be isolated from oral/cloacal 
swabs. On the day of inoculation, all of the birds had HI 
antibody titers of ＜2 and ELISA absorbance of ＜0.2. All 
the virulent NDV-infected birds displayed severe depression 
between 2 and 5 days postinoculation (dpi). Sixty seven 
percent (8/12) of affected birds died showing severe 
depression between 3 and 5 dpi. The remaining four birds 
(chicken Nos. 5-1, 5-2, 5-5 and 5-12) survived up to 7 dpi. 
They were humanely sacrificed after sampling (sera and 
cloacal swabs) 7 dpi. Virulent NDV was re-isolated 7 dpi 
from all of the affected birds when cloacal swab samples 
were inoculated into SPF embryonated chicken eggs. No 
virus was isolated from cloacal swabs taken 7 dpi from 
mock-infected control birds.
Sera taken 0 dpi and 7 dpi from infected and control 
chickens were employed to detect the peptide-bound 
antibodies. Anti-NDV antibodies were detected in all of the 
four birds surviving to 7 dpi and their average HI titers ranged 
from 32 to 256. The 7 dpi sera of the four chickens (5-1, 5-2, 
5-5 and 5-12) had significantly increased ELISA PP values 
(PP value of ranging from 84 to 314) compared to the 0 dpi 
sera (PP value of ranging from 2 to 14) (p＜ 0.05) (Fig. 2). 
All control chickens (n = 12) had HI antibody titers of ＜2 
and ELISA PP values of ＜20 during the experiment.
Reactivity of other virulence motif to sera from NDV 
infected chickens
We next used pELISA to examine how sera obtained 7 dpi 
from virulent NDV infected chickens reacted to four synthetic 
peptides containing three virulence motif (KRQKRF, RRQRRF 
and RRRKRF) or avirulence motif (GRQGRL) sequences. 
Four 7 dpi sera (chicken Nos. 5-1, 5-2, 5-5 and 5-12) were 
tested. A peptide containing avirulence motif (
112GRQGRL
117) 
was also included. All of the pre-infection (0 dpi) sera (HI 
titers of ＜2) had a mean absorbance of ＜0.2 for peptides 
KRQKRF, RRQRRF, RRRKRF and GRQGRL. However, 
the 7 dpi sera for the three peptides KRQKRF and RRQRRF, 
RRRKRF showed significantly increased ELISA absorbance 
compared to the 0 dpi sera (p＜0.05); 1.64 ± 0.05 vs. 0.10 
± 0.05 for peptide RRQRRF, 1.11 ± 0.08 vs. 0.10 ± 0.05 for 
peptide RRRKRF and 2.01 ± 0.15 vs. 0.10 ± 0.19 for peptide 
RRQKRF (Fig. 3). However, peptide GRQGRL had ELISA 
absorbance of ＜0.2 with the 7 dpi sera as well as the 0 dpi.
Reactivity to sera taken from surviving chickens on 
NDV outbreak farms
We tested the sera taken from surviving birds (n = 93) on 
five ND outbreak farms and apparently healthy birds (n = 
40) on vaccinated farms without ND outbreak by pELISA 
(Table 1). Synthetic peptide bearing RRQKRF virulence 
motif was used as antigen for pELISA. The pELISA positive 
signals (PP value ＞20%) were detected in all of five ND 
outbreak farms. The ELISA-positive rates of farms A, B, C, 
D and E were 90% (18/20), 91% (20/22), 65% (13/20), 60% 
(9/15) and 88% (14/16), respectively. When the sera taken 
from farms A and B were subjected to the HI test, all except Antigenic and immunogenic NDV virulence motif    209
two of the ELISA positive samples of farm B also had HI 
antibody (HI titer of ≥2) to NDV. ELISA negative sera (2 
for farm A and 2 for farm B) were also HI antibody negative. 
In commercial farms F and G without ND outbreak, none 
but one of the sera reacted with synthetic peptide in the 
pELISA even though 85% and 55% of the sera tested positive 
for HI test.
Discussion
Our epitope mapping of virulence motif 
112RRQKRF
117 
revealed that the mAb 4G2 specific for the virulence motif 
was directed to 
115KRF
117. Synthetic peptides RRQRRF, 
KRQKRF, RRQRRF and RRRKRF reacted with sera 
obtained from chicken after infection with virulent NDV 
having the RRQKRF
 motif in indirect ELISA, indicating 
that the difference of lysine (K) and arginine (R) at position 
115 of the virulence motif is acceptable to antisera against 
virulent NDV. In addition, anti-virulent NDV antisera did 
not react with peptide GRQGRL having avirulence motif, 
indicating that the R to G and/or F to L substitutions result 
in lack of reactivity with peptide RRQKRF. Collectively, 
our findings suggest that the K/R-R-Fsequence of the 
virulence motif RRQKRF may have the potential to serve 
as a B-cell epitope and, significantly, that a phenylalanine 
(F) at position 117 may be critical for B-cell immune 
response as demonstrated in mAb 4G2. 
The paramyxovirus F protein is a type I integral membrane 
glycoprotein which is synthesized as a precursor (F0) in the 
cytoplasm of the cell. During transit to the cell surface 
through the trans-Golgi network, the F0 precursor is cleaved 
by a host cell protease to produce two biologically active 
subunits, F1 and F2, held together by disulfide bonds [20]. 
In virulent NDV, cleavage usually takes place between R
116 
and F
117 [4,5,24] and then the basic amino acids (i.e., 
115KR
116) exposed are trimmed and removed by a 
carboxypeptidase from the F2 C-termini [10,11,19]. Thus 
the continuous sequence 
115K/R-R-F
117 is not likely to form 
a B cell epitope on the infectious virus particles, suggesting 
that B-cell epitope having KRF sequence might be 
discontinuous rather than continuous. Here it should be 
noted that virulent NDV possess the characteristic sequence 
K/R
113-R
114, and biologically active F1 and F2 subunits of 
the parmyxovirus are linked to each other by a disulfide bond 
[9]. This allows the basic amino acids (R/K
112-R
113) at the 
C-termini of the F2 subunit to locate closely with F
117at the 
N-termini of the F1 subunit. It is therefore more feasible that 
such cross-linkage between F1 and F2 subunits may result 
in a discontinuous conformational epitope R/K
112-R
113- 
X-X-X-F
117. 
Diagnostically, polyclonal anti-peptide sera to peptides 
whose sequences mimic the F2 C-termini (i.e. 
112RRQ
114) 
have been used to capture virulent NDV isolates even though 
a defined amino acid sequence ofthe epitope has yet to be 
determined [12,16,25]. However, a reported limitation of 
these anti-peptide antisera was that they occasionally did not 
react with some NDV isolates even with 
112RRQ
114 motif 
sequences [16,25]. The reason for this is unclear, although 
ananomalous cleavage/activation process was cited as a 
reason for their lack of reactivity [16,25]. As mentioned 
above, the KRF section of the virulence motif can evoke 
antibody response, suggesting that anti-KRF antibody 
might react with virulent NDV strains. Thus, use of anti- 
peptide anti-sera to a peptide mimicking the entire virulence 
motif RRQKRF might broaden the spectrum of virulent 
NDV isolates to be captured in immunoassays than previously 
used anti-peptide antisera to RRQ (the F2 C-termini) alone. 
Currently, commercially available vaccines (both live and 
killed) that are produced using lentogenic NDV strains are 
widely used for controlling and preventing ND. Because of 
this, anti-sera to the virulence motif have had the potential 
to rapidly differentiate virulent NDV isolates and avirulent 
NDV strains (i.e. lentogenic vaccine strains) using antigen 
detection assays [12,16,25]. In this study, the 7 dpi sera 
obtained from infected chickens with virulent NDV (bearing 
RRQKRF motif) cross reacted with synthetic peptides 
containing other virulence motifs but not avirulence motifs. 
This also implies that the virulence motif could be applied 
for pathotype-specific serologic immunoassay if antibodies 
bound to the motif are specifically and sensitively detected 
in NDV infected chickens. If so, the virulence motif would 
be a target for a serological test that allows infected birds to 
be distinguished from vaccinated birds. 
For this purpose, we performed pELISA based on the 
synthetic peptide bearing thevirulence motif (RRQKRF) to 
determine whether pELISA could differentiate infected 
birds from vaccinated chickens under field conditions. As 
shown in Table 1, most of the sera had HI antibody regardless 
of virulent NDV infection since all birds had received 
vaccination two times or more. However, there was a 
significant difference (p  < 0.05) in pELISA reactivity 
between ND outbreak farms (60∼91%) and farms without 
ND outbreak (0∼5%). This suggests that most birds with 
ELISA positive results on ND outbreak farms produce 
antibodies to the RRQKRF motif following virulent NDV 
infection, as demonstrated in SPF chickens after challenge 
with virulent NDV. In contrast, the ELISA-positive signal 
in a bird on farm F is presumably non-specific considering 
that the bird was still apparently healthy at that time of 
sampling.
In conclusion, we were the first to examine whether 
pELISA can discriminate virulent NDV-infected birds 
from birds that have been vaccinated with whole virus 
vaccines. Our findings indicate that serological testing 
using a virulence motif has the potential to differentiate 
infected from vaccinated birds. This suggests that tests like 
the pELISA may be suitable as a differentiation between 
infected and vaccinated animals (DIVA) serological tests 210    Kang-Seuk Choi et al.
that can be used to monitor herds vaccinated with whole 
virus vaccines, perhaps in combination with antigen and/or 
virus isolation methods. It should be noted that while we 
did not test the ability of the pELISA to detect virulent 
NDV strains with different virulence motifs such as 
KRQKRF, we found that the RRQKRF-specific antibodies 
could cross-react quite well with these alternate virulence 
motifs. Thus, it may be that antibodies raised against the 
alternate virulence motifs exhibit similar cross-reactivity. 
Further studies on development of a virulence motif-based 
immunoassay for DIVA serological test are in progress.
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